Compare CVR & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CVR | MODD |
|---|---|---|
| Founded | 1920 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6M | 11.2M |
| IPO Year | 1995 | 2019 |
| Metric | CVR | MODD |
|---|---|---|
| Price | $10.23 | $3.35 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 1.7K | ★ 347.6K |
| Earning Date | 05-12-2026 | 02-17-2026 |
| Dividend Yield | ★ 1.06% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $27,890,260.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 3.35 | N/A |
| 52 Week Low | $8.50 | $0.12 |
| 52 Week High | $15.00 | $6.16 |
| Indicator | CVR | MODD |
|---|---|---|
| Relative Strength Index (RSI) | 50.25 | 55.57 |
| Support Level | $9.42 | $3.13 |
| Resistance Level | $10.35 | $5.84 |
| Average True Range (ATR) | 0.19 | 0.52 |
| MACD | 0.01 | 0.07 |
| Stochastic Oscillator | 40.17 | 75.86 |
Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, marketing and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.